Modulation of thymic selection by expression of an immediate-early gene, early growth response 1 (Egr-1)

被引:45
作者
Miyazaki, T
Lemonnier, FA
机构
[1] Basel Inst Immunol, CH-4005 Basel, Switzerland
[2] Inst Pasteur, Unite Immunite Cellulaire Antivirale, F-75724 Paris 15, France
关键词
Egr-1; positive selection; T cell; avidity; transgenic mouse;
D O I
10.1084/jem.188.4.715
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The potential involvement of early growth response (Egr)-1, a zinc-finger transcription factor belonging to the immediate-early genes, in positive/negative selection of thymocytes has been implicated by its expression in the population of CD4(+)CD8(+) double positive (DP) cells undergoing selection. To further investigate this possibility, transgenic mice overexpressing Egr-1 in thymocytes were bred with a transgenic mouse line expressing a T cell receptor (TCR) recognizing the H-Y male antigen in the context of H-2(b) class I major histocompatibility complex (MHC) molecules. In Egr-1/TCR H-Y double-transgenic mice, efficient positive selection of H-Y CD8(+) T cells occurred, even in mice on either a nonselecting H-2(d) background or a beta 2-microglobulin (beta 2m)-deficient background in which the expression of class I MHC heavy chains is extremely low; no positive selection was observed on a K(b-/-)Db(-/-)beta 2m(-/-) background where class I MHC expression is entirely absent. Similarly, when the Egr-1 transgene was introduced into a class II MHC-restricted TCR transgenic mouse line, Egr-1/TCR double-transgenic mice revealed increased numbers of CD4(+) T cells selected by class II MHC, as well as significant numbers or CD8(+) T cells selected by class I MHC (for which the transgenic TCR might have weak affinity). Thus, Egr-1 overexpression allows positive selection of thymocytes via TCR-MHC interactions of unusually low avidity, possibly by lowering the threshold of avidity required for positive selection. Supporting this possibility, increased numbers of alloreactive T cells were positively selected in Egr-1 transgenic mice, resulting in a strikingly enhanced response against allo-MHC. These results suggest that expression of Egr-1 and/or its target gene(s) may directly influence the thresholds required for thymocyte selection.
引用
收藏
页码:715 / 723
页数:9
相关论文
共 31 条
[1]   Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[2]   PEPTIDE CONTRIBUTES TO THE SPECIFICITY OF POSITIVE SELECTION OF CD8+ T-CELLS IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
VANKAER, L ;
SCHUMACHER, TNM ;
PLOEGH, HL ;
TONEGAWA, S .
CELL, 1993, 73 (05) :1041-1049
[3]   Positive selection of T cells: Fastidious or promiscuous? [J].
Benoist, C ;
Mathis, D .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (02) :245-249
[4]   FUNCTIONALLY CONFORMED FREE CLASS-I HEAVY-CHAINS EXIST ON THE SURFACE OF BETA(2) MICROGLOBULIN NEGATIVE CELLS [J].
BIX, M ;
RAULET, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) :829-834
[5]  
CALNAN BJ, 1995, IMMUNITY, V3, P273
[6]   MICE LACKING MHC CLASS-II MOLECULES [J].
COSGROVE, D ;
GRAY, D ;
DIERICH, A ;
KAUFMAN, J ;
LEMEUR, M ;
BENOIST, C ;
MATHIS, D .
CELL, 1991, 66 (05) :1051-1066
[7]   E2F-1 functions in mice to promote apoptosis and suppress proliferation [J].
Field, SJ ;
Tsai, FY ;
Kuo, F ;
Zubiaga, AM ;
Kaelin, WG ;
Livingston, DM ;
Orkin, SH ;
Greenberg, ME .
CELL, 1996, 85 (04) :549-561
[8]   RECOGNITION OF BETA-2-MICROGLOBULIN-NEGATIVE (BETA-2M-) T-CELL BLASTS BY NATURAL-KILLER-CELLS FROM NORMAL BUT NOT FROM BETA-2M- MICE - NONRESPONSIVENESS CONTROLLED BY BETA-2M- BONE-MARROW IN CHIMERIC MICE [J].
HOGLUND, P ;
OHLEN, C ;
CARBONE, E ;
FRANKSSON, L ;
LJUNGGREN, HG ;
LATOUR, A ;
KOLLER, B ;
KARRE, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10332-10336
[9]   POSITIVE SELECTION OF CD8+ T-CELLS INDUCED BY MAJOR HISTOCOMPATIBILITY COMPLEX BINDING PEPTIDES IN FETAL THYMIC ORGAN-CULTURE [J].
HOGQUIST, KA ;
GAVIN, MA ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1469-1473
[10]  
KAYE J, 1992, J IMMUNOL, V148, P3342